-+ 0.00%
-+ 0.00%
-+ 0.00%

RADIOPHARM THERANOSTICS - TO INITIATE U.S. PHASE 3 PIVOTAL TRIAL OF RAD101 IN Q4 2026

路透·07/22/2026 11:00:00

登錄查看新聞詳情